Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Effects of Continuous IV DMT
NCT07693257Phase 1Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of DMT (2 arms). Primary endpoint: Blood Oxygen Level Dependent Signaling up to 3 months. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
DMT
Beyond the preview
Go deeper on NCT07693257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07693257.